GRF/P SM stock pitch

Added to YB: 2024-03-22

Pitch date: 2024-03-22

Grifols, S.A.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Market Cap

EUR 6.7B

Pitch Price

EUR 7.81

Price Target

N/A

Dividend

2.72%

EV/EBITDA

9.86

P/E

20.19

EV/Sales

2.39

Sector

Biotechnology

A summary for this pitch has not been created yet.